We are live on ! Find out more
ISEE

IVERIC bio

Delisted

ISEE was delisted on the 10th of July, 2023.

63 hedge funds and large institutions have $22.6M invested in IVERIC bio in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

451% more call options, than puts

Call options by funds: $248K | Put options by funds: $45K

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

6.97% less ownership

Funds ownership: 52.53% → 45.56% (-7%)

7% less funds holding

Funds holding: 68 → 63 (-5)

14% less capital inflows, than outflows

Capital inflows: $6.85M | Capital outflows: $7.98M

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

38% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 24

Holders
63
Holders Change
-5
Holders Change %
-7.35%
% of All Funds
1.4%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
7
Increased
15
Reduced
24
Closed
11
Calls
$248K
Puts
$45K
Net Calls
+$203K
Net Calls Change
-$96K

ISEE Hedge Fund Activity: Q4 2018 in Review

63 of the 4,507 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio (ISEE) for Q4 2018, worth a combined $22.6M — down 50% from $44.9M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ISEE and 7 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 15 added.

The largest buyer was Stonepine Capital Management, adding an estimated $3.39M. The largest seller was AJO LP, exiting entirely with an estimated $2.57M sold.

  • 63 institutional investors held IVERIC bio (ISEE) as of Q4 2018, down from 68 in Q3 2018.
  • Funds reported $22.6M of IVERIC bio stock for Q4 2018, down 50% quarter-over-quarter.
  • 7 funds opened new IVERIC bio positions in Q4 2018 and 11 closed out, a net change of -4 holders.
  • The largest IVERIC bio buyer in Q4 2018 was Stonepine Capital Management, an estimated $3.39M added.
  • The largest IVERIC bio seller in Q4 2018 was AJO LP, an estimated $2.57M sold.

Based on aggregated 13F filings for Q4 2018.